EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nationwide survey on HER2 and PD-L1 testing practices in gastric cancer across Japan

Hiroyuki Abe, Takeshi Kuwata, Ryoji Kushima, Tetsuo Ushiku iD

Gastric Cancer · 2025-03 · 28 (2) · 294-300

DOI: 10.1007/s10120-024-01571-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gastric Cancer, online erschienen am 10.12.2024. Verfasst von Hiroyuki Abe und 3 weiteren Autor:innen. Beteiligte Einrichtung: Japanese Gastric Cancer Association, Kyoto, Japan. Hauptthemen laut MEDLINE: Stomach Neoplasms, Erb-b2 Receptor Tyrosine Kinases, B7-H1 Antigen, Biomarkers, Tumor. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The University of Tokyo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Since HER2 and PD-L1 testing are key to selecting drugs for first-line treatments in advanced gastric cancer, evaluating differences in these tests among institutions is necessary to standardize treatment.

Methods

A questionnaire survey was conducted targeting institutions certified by the Japanese Gastric Cancer Association.

Results

Responses were obtained from 155 institutions. Most institutions performed HER2 testing in-house, while PD-L1 tests were largely outsourced. HER2 scores and PD-L1 CPS rates showed greater variability across institutions than anticipated. In the pre-analytic phase, 10% neutral buffered formalin was commonly used, with fixation practices generally following guidelines. Overall, the impact of fixation-related factors was limited, but in surgical specimens, longer fixation was associated with a higher proportion of score 0/1+ and a lower proportion of score 3+. When examining HER2 scores by institution, if a particular score had a high (or low) frequency in biopsy, the same trend was also seen in surgical specimens.

Conclusions

These findings suggest that not only factors related to specimen preparation, but also biases in evaluation criteria among pathologists may contribute to the significant variability among institutions. Standardization of pre- and post-analytic phases, coupled with appropriate training, is essential to achieve consistent gastric cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsErb-b2 Receptor Tyrosine KinasesB7-H1 AntigenBiomarkers, TumorPractice Patterns, Physicians'HumansJapanSurveys and QuestionnairesImmunohistochemistry

Stichwörter der Autor:innen

Biomarker testingGastric cancerHER2PD-L1Questionnaire survey

Substanzen

Erb-b2 Receptor Tyrosine KinasesB7-H1 AntigenBiomarkers, TumorERBB2 protein, humanCD274 protein, human

Autor:innen und Institutionen

  • Japanese Gastric Cancer Association, Kyoto, Japan.
  • Department of Pathology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
  • Department of Genetic Medicine and Services, National Cancer Center Hospital East, Kashiwa, Japan.
  • Department of Pathology, Shiga University of Medical Science, Otsu, Japan.
  • Japanese Gastric Cancer Association, Kyoto, Japan. usikut@g.ecc.u-tokyo.ac.jp.
  • Department of Pathology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan. usikut@g.ecc.u-tokyo.ac.jp.

ORCID-Profile: Tetsuo Ushiku

Förderung

  • The University of Tokyo

Zitieren

APA

Abe, H., Kuwata, T., Kushima, R., & Ushiku, T. (2025). Nationwide survey on HER2 and PD-L1 testing practices in gastric cancer across Japan. Gastric Cancer, 28(2), 294-300. https://doi.org/10.1007/s10120-024-01571-w

Vancouver

Abe H, Kuwata T, Kushima R, Ushiku T. Nationwide survey on HER2 and PD-L1 testing practices in gastric cancer across Japan. Gastric Cancer. 2025;28(2):294-300. doi:10.1007/s10120-024-01571-w

BibTeX
@article{Abe2025,
  author = {Abe, Hiroyuki and Kuwata, Takeshi and Kushima, Ryoji and Ushiku, Tetsuo},
  title = {Nationwide survey on HER2 and PD-L1 testing practices in gastric cancer across Japan},
  journal = {Gastric Cancer},
  year = {2025},
  volume = {28},
  number = {2},
  pages = {294--300},
  doi = {10.1007/s10120-024-01571-w}
}
Kostenlos starten →